The Serum Institute of India was supposed to supply vaccines not just to India, but to the entire Global South. Now, with cases surging, there aren’t nearly enough vaccines for India’s population, not to mention the many countries that are relying on it. How did such a successful institution come up so short? And what are the costs of that failure?
Guest: Samanth Subramanian, senior reporter at Quartz
Learn more about your ad choices. Visit megaphone.fm/adchoices